Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19

GÖRMEZ S., Gumusel H. K., Ekicibasi E., DEĞİRMENCİOĞLU A., PAUDEL A., Akan G., ...Daha Fazla

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.122, sa.8, ss.582-589, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 122 Sayı: 8
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4149/bll_2021_093
  • Dergi Adı: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.582-589
  • Anahtar Kelimeler: COVID-19, SARS-CoV-2, thrombosis, antithrombotic therapy, low-molecular-weight heparin, D-dimer, enoxaparin, PROPENSITY SCORE, COAGULOPATHY
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

OBJECTIVES: Low molecular weight heparin (LMWH) may provide beneficial effects on outcomes of COVID-19. We aimed to examine the impact of LMWH treatment on clinical outcomes (duration of hospitalization, admission to intensive care unit, the requirement for mechanical ventilation, and death) of COVID-19 patients with normal D-dimer levels at admission.